David Allsop - Concepedia

Author

David Allsop

Also Known As

Allsop D, Allsop, David, Bentham Science Publisher David Allsop, D Allsop, D. ALLSOP, D. Allsop, DAVID ALLSOP, David ALLSOP, David Allsop

216

Publications

15.4K

Citations

H-Index

131

Concepts

All Affiliations

Lancaster University University of Manchester Salford Royal Hospital Kyoto Prefectural University of Medicine Tokyo Institute of Psychiatry

About

David Allsop is an author at Lancaster University specializing in medicine, alzheimer's disease, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	57	6.7K
2	Natural Sciences	18	18	3.5K
3	Health Sciences	5	5	748
4	Engineering	3	3	1.2K
5	Humanities	1	1	520

David Allsop

106

Publications

11.1K

Citations

H-Index

Page 1

	Year	Citations
Magnetite pollution nanoparticles in the human brain Barbara A. Maher, Imad A. M. Ahmed, Vassil Karloukovski, Proceedings of the National Academy of Sciences NanoparticlesMagnetic PropertiesEngineeringMagnetic ResonanceNanotoxicology	2016	998
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides Tobias Hartmann, Sophie Bieger, Babara Brühl, Nature Medicine Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryProtein FoldingNatural Sciences	1997	709
Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's disease Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou, The FASEB Journal PathologySoluble AggregatesNeurochemical BiomarkersOligomeric FormsDegenerative Pathology	2006	700
α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma Omar M. A. El‐Agnaf, Sultan A. Salem, Katerina E. Paleologou, The FASEB Journal Neurodegenerative DiseasesMedicineConditioned Culture MediaExtracellular Biological FluidsHuman Plasma	2003	576
The occult aftermath of boxing. G.W. Roberts, David Allsop, C.J. Bruton Journal of Neurology Neurosurgery & Psychiatry PathologyHead InjuryOccult AftermathNeurochemical BiomarkersFolklore Tradition	1990	520
Decreased α-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson’s disease Takahiko Tokuda, Sultan A. Salem, David Allsop, Biochemical and Biophysical Research Communications Neurodegenerative DiseasesAged IndividualsNeurobiology Of DiseaseDegenerative DiseasesCerebrospinal Fluid	2006	430
Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome Harutsugu Tatebe, Takashi Kasai, Takuma Ohmichi, Molecular Neurodegeneration	2017	264
High‐molecular‐weight β‐amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients Hiroaki Fukumoto, Takahiko Tokuda, Takashi Kasai, The FASEB Journal Alzheimer PatientsNeurochemical BiomarkersHmw Abeta OligomersSocial SciencesAlzheimer's Disease	2010	253
Hydrogen Peroxide Is Generated during the Very Early Stages of Aggregation of the Amyloid Peptides Implicated in Alzheimer Disease and Familial British Dementia Brian J. Tabner, Omar M. A. El‐Agnaf, Stuart Turnbull, Journal of Biological Chemistry Familial British DementiaLipid PeroxidationMolecular BiologyNeurochemical BiomarkersRedox Biology	2005	238
Detection of elevated levels of soluble -synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies Katerina E. Paleologou, Christine Lund Kragh, David Mann, Brain Neurochemical BiomarkersAlzheimer's DiseaseProtein MisfoldingNeurologyBrain Pathology	2008	224

Page 1